ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients.

Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.